Cheng Zhou

Cheng Zhou is a seasoned professional in the biomedical and medical engineering fields, currently serving as the Product Manager for Cell and Gene Therapy at Agilent Technologies since December 2022. Prior to this role, Cheng held various positions at GenScript from February 2019 to December 2022, including Global Market Development Manager, Global Product Manager, and Senior Technical Account Manager. Cheng's academic background includes a Doctor of Philosophy (Ph.D.) in Biomedical/Medical Engineering from the University of Iowa, completed in 2016, and a Master's Degree in the same field from the same institution in 2013. Cheng began the academic journey at Zhejiang University of Technology, earning a Bachelor of Engineering in Bioengineering and Biomedical Engineering in 2011. Additional experience includes a Postdoctoral Fellowship at the University of Pennsylvania from July 2017 to February 2019 and a Graduate Research Assistant role at the University of Iowa from February 2012 to July 2017.